バイオテクノロジー試薬市場- 世界の産業規模、シェア、動向、機会、予測、技術別、用途別、地域別、競争別、2020-2030年予測

バイオテクノロジー試薬の世界市場は、2024年に780億2,000万米ドルと評価され、予測期間中にCAGR 7.22％で成長し、2030年には1,188億1,000万米ドルに達すると予測されています。

この市場は、より広範なライフサイエンス分野の重要な構成要素であり、研究、診断、バイオテクノロジー生産に使用される試薬を包含しています。バイオテクノロジー試薬は、研究者や研究機関が分子、細胞、組織などの生物学的実体を調査・操作するために不可欠なツールです。その用途は、ゲノム解読、タンパク質分析、分子診断、治療開発など多岐にわたり、ゲノミクス、プロテオミクス、再生医療など様々な分野の進歩を支えています。

市場促進要因

バイオテクノロジー研究の進展

主な市場課題

規制とコンプライアンスのハードル

主要市場動向

個別化医療に対する需要の高まり

目次

第1章 概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 顧客の声

第5章 世界のバイオテクノロジー試薬市場展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • 技術別（ライフサイエンス試薬、分析試薬）
  • 用途別（タンパク質合成・精製、遺伝子発現、DNA・NA分析、薬物検査、その他）
  • 地域別
  • 企業別（2024）
• 市場マップ

第6章 北米のバイオテクノロジー試薬市場展望

• 市場規模・予測
• 市場シェア・予測
• 北米：国別分析
  • 米国
  • カナダ
  • メキシコ

第7章 欧州のバイオテクノロジー試薬市場展望

• 市場規模・予測
• 市場シェア・予測
• 欧州：国別分析
  • ドイツ
  • 英国
  • イタリア
  • フランス
  • スペイン

第8章 アジア太平洋地域のバイオテクノロジー試薬市場展望

• 市場規模・予測
• 市場シェア・予測
• アジア太平洋地域：国別分析
  • 中国
  • インド
  • 日本
  • 韓国
  • オーストラリア

第9章 南米のバイオテクノロジー試薬市場展望

• 市場規模・予測
• 市場シェア・予測
• 南米：国別分析
  • ブラジル
  • アルゼンチン
  • コロンビア

第10章 中東・アフリカのバイオテクノロジー試薬市場展望

• 市場規模・予測
• 市場シェア・予測
• 中東・アフリカ：国別分析
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦

第11章 市場力学

• 促進要因
• 課題

第12章 市場動向と発展

• 最近の動向
• 製品上市
• 合併と買収

第13章 世界のバイオテクノロジー試薬市場：SWOT分析

第14章 競合情勢

• Abbott Laboratories Inc.
• Agilent Technologies
• Danaher Corporation（Beckman Coulter Inc.）
• Becton Dickinson & Company
• Bio-Rad Laboratories
• bioMerieux SA
• Siemens Healthcare
• Merck KGaA（Sigma Aldrich Corporation）
• Thermo Fisher Scientific Inc.
• Waters Corporation

第15章 戦略的提言

第16章 調査会社について・免責事項

The Global Biotechnology Reagents Market was valued at USD 78.02 billion in 2024 and is projected to reach USD 118.81 billion by 2030, growing at a CAGR of 7.22% during the forecast period. This market is a crucial component of the broader life sciences sector, encompassing reagents used in research, diagnostics, and biotechnological production. Biotechnology reagents are indispensable tools that enable researchers and institutions to study and manipulate biological entities such as molecules, cells, and tissues. Their applications span genomic sequencing, protein analysis, molecular diagnostics, and therapeutic development, supporting advancements in various fields including genomics, proteomics, and regenerative medicine.

Key Market Drivers

Advancements in Biotechnology Research

Continued progress in biotechnology research is a major factor propelling the growth of the Biotechnology Reagents Market. Innovations in areas such as genomics, proteomics, molecular biology, and regenerative medicine are driving demand for a wide spectrum of high-quality, specialized reagents. The dramatic reduction in the cost of whole genome sequencing-from nearly $100 million in 2001 to under $200 today-has accelerated genomic research, increasing the need for reagents used in DNA/RNA extraction, PCR, and sequencing workflows. In proteomics, the adoption of mass spectrometry and high-throughput analysis has spurred the requirement for reagents like antibodies, dyes, and enzymes. These are essential for protein detection, characterization, and quantification, supporting developments in diagnostics, biomarker discovery, and drug research. As research output in these domains expands, so too does the demand for precision reagents that enable deeper insights into biological systems.

Key Market Challenges

Regulatory and Compliance Hurdles

The biotechnology reagents sector faces complex regulatory and compliance barriers that can restrict market expansion. Regulatory authorities such as the FDA and EMA enforce rigorous standards to ensure the safety and quality of reagents used in clinical applications. Achieving compliance involves significant investments in development and production. Furthermore, companies must continuously adapt to evolving regulatory frameworks, which increases operational complexity. International sales are further complicated by the need to meet diverse regulatory standards across multiple jurisdictions, often slowing global expansion. These challenges demand considerable financial and time resources, potentially delaying innovation and hindering the market's overall growth.

Key Market Trends

Growing Demand for Personalized Medicine

The rising focus on personalized medicine is a transformative trend influencing the biotechnology reagents market. Personalized medicine involves customizing treatments based on individual genetic profiles and other health indicators, which requires advanced tools for DNA/RNA analysis, biomarker identification, and targeted drug development. As demand for genetic testing and pharmacogenomics increases, so does the need for specialized reagents in these processes. Reagents play a pivotal role in enabling precision diagnostics and supporting the development of therapies tailored to specific patient groups. This surge in personalized approaches to healthcare is expected to significantly boost reagent demand, driving innovation and shaping future market growth.

Key Market Players

• Abbott Laboratories
• Agilent Technologies
• Danaher Corporation (Beckman Coulter Inc.)
• Becton Dickinson & Company
• Bio-Rad Laboratories
• bioMerieux SA
• Siemens Healthcare
• Merck KGaA (Sigma Aldrich Corporation)
• Thermo Fisher Scientific Inc.
• Waters Corporation

Report Scope:

In this report, the Global Biotechnology Reagents Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Biotechnology Reagents Market, By Technology:

• Life Science Reagents
• Analytical Reagents

Biotechnology Reagents Market, By Application:

• Protein Synthesis and Purification
• Gene Expression
• DNA and RNA Analysis
• Drug Testing
• Other

Biotechnology Reagents Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Biotechnology Reagents Market.

Available Customizations:

Global Biotechnology Reagents market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.4. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Biotechnology Reagents Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Technology (Life Science Reagents, Analytical Reagents)
  • 5.2.2. By Application (Protein Synthesis and Purification, Gene Expression, DNA and NA Analysis, Drug Testing, Other)
  • 5.2.3. By Region
  • 5.2.4. By Company (2024)
• 5.3. Market Map

6. North America Biotechnology Reagents Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Technology
  • 6.2.2. By Application
  • 6.2.3. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Biotechnology Reagents Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Technology
      • 6.3.1.2.2. By Application
  • 6.3.2. Canada Biotechnology Reagents Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Technology
      • 6.3.2.2.2. By Application
  • 6.3.3. Mexico Biotechnology Reagents Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Technology
      • 6.3.3.2.2. By Application

7. Europe Biotechnology Reagents Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Technology
  • 7.2.2. By Application
  • 7.2.3. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Biotechnology Reagents Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Technology
      • 7.3.1.2.2. By Application
  • 7.3.2. United Kingdom Biotechnology Reagents Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Technology
      • 7.3.2.2.2. By Application
  • 7.3.3. Italy Biotechnology Reagents Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecasty
      • 7.3.3.2.1. By Technology
      • 7.3.3.2.2. By Application
  • 7.3.4. France Biotechnology Reagents Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Technology
      • 7.3.4.2.2. By Application
  • 7.3.5. Spain Biotechnology Reagents Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Technology
      • 7.3.5.2.2. By Application

8. Asia-Pacific Biotechnology Reagents Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Technology
  • 8.2.2. By Application
  • 8.2.3. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Biotechnology Reagents Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Technology
      • 8.3.1.2.2. By Application
  • 8.3.2. India Biotechnology Reagents Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Technology
      • 8.3.2.2.2. By Application
  • 8.3.3. Japan Biotechnology Reagents Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Technology
      • 8.3.3.2.2. By Application
  • 8.3.4. South Korea Biotechnology Reagents Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Technology
      • 8.3.4.2.2. By Application
  • 8.3.5. Australia Biotechnology Reagents Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Technology
      • 8.3.5.2.2. By Application

9. South America Biotechnology Reagents Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Technology
  • 9.2.2. By Application
  • 9.2.3. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Biotechnology Reagents Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Technology
      • 9.3.1.2.2. By Application
  • 9.3.2. Argentina Biotechnology Reagents Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Technology
      • 9.3.2.2.2. By Application
  • 9.3.3. Colombia Biotechnology Reagents Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Technology
      • 9.3.3.2.2. By Application

10. Middle East and Africa Biotechnology Reagents Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Technology
  • 10.2.2. By Application
  • 10.2.3. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Biotechnology Reagents Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Technology
      • 10.3.1.2.2. By Application
  • 10.3.2. Saudi Arabia Biotechnology Reagents Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Technology
      • 10.3.2.2.2. By Application
  • 10.3.3. UAE Biotechnology Reagents Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Technology
      • 10.3.3.2.2. By Application

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Developments
• 12.2. Product Launches
• 12.3. Mergers & Acquisition

13. Global Biotechnology Reagents Market: SWOT Analysis

14. Competitive Landscape

• 14.1. Abbott Laboratories Inc.
  • 14.1.1. Business Overview
  • 14.1.2. Application Offerings
  • 14.1.3. Recent Developments
  • 14.1.4. Key Personnel
  • 14.1.5. SWOT Analysis
• 14.2. Agilent Technologies
• 14.3. Danaher Corporation (Beckman Coulter Inc.)
• 14.4. Becton Dickinson & Company
• 14.5. Bio-Rad Laboratories
• 14.6. bioMerieux SA
• 14.7. Siemens Healthcare
• 14.8. Merck KGaA (Sigma Aldrich Corporation)
• 14.9. Thermo Fisher Scientific Inc.
• 14.10. Waters Corporation

15. Strategic Recommendations

16. About Us & Disclaimer